Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 617
5
Diseases
3
Unique genes
0.357
Avg. similarity score
Dend syndrome
Most-connected disease (4 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Dend syndrome
Diabetes, permanent neonatal, with or without neurologic features
Diazoxide-resistant focal hyperinsulinism due to kir6.2 deficiency
Hyperinsulinemic hypoglycemia, familial, 2
Deafness, autosomal recessive 94
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Dend syndrome | 4 | 4 | 3 |
| Diabetes, permanent neonatal, with or without neurologic features | 3 | 3 | 1 |
| Diazoxide-resistant focal hyperinsulinism due to kir6.2 deficiency | 3 | 3 | 1 |
| Hyperinsulinemic hypoglycemia, familial, 2 | 3 | 3 | 1 |
| Deafness, autosomal recessive 94 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| KCNJ11 | 4 / 5 | Dend syndrome, Diabetes, permanent neonatal, with or without neurologic features, Diazoxide-resistant focal hyperinsulinism due to kir6.2 deficiency, Hyperinsulinemic hypoglycemia, familial, 2 |
| NARS2 | 2 / 5 | Deafness, autosomal recessive 94, Dend syndrome |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Defective ABCC8 can cause hypoglycemias and hyperglycemias | Reactome | 2 / 2 | 4,003× | 4.16e-8 | 2.60e-6 ✓ sig. |
| ATP sensitive Potassium channels | Reactome | 2 / 4 | 2,002× | 2.50e-7 | 1.25e-5 ✓ sig. |
| Regulation of insulin secretion | Reactome | 2 / 16 | 500× | 4.99e-6 | 1.64e-4 ✓ sig. |
| Type II diabetes mellitus | KEGG | 2 / 47 | 170× | 4.49e-5 | 1.00e-3 ✓ sig. |
| Insulin secretion | KEGG | 2 / 86 | 93.1× | 1.51e-4 | 2.64e-3 ✓ sig. |
| Defective ABCC9 causes dilated cardiomyopathy 10, familial atrial fibrillation 12 and hypertrichotic osteochondrodysplasia | Reactome | 1 / 2 | 2,002× | 5.00e-4 | 6.67e-3 ✓ sig. |
| ABC transporters | KEGG | 1 / 45 | 89.0× | 1.12e-2 | 6.10e-2 |
| Ion homeostasis | Reactome | 1 / 54 | 74.1× | 1.34e-2 | 6.79e-2 |
| GnRH secretion | KEGG | 1 / 65 | 61.6× | 1.62e-2 | 7.58e-2 |
| Aminoacyl-tRNA biosynthesis | KEGG | 1 / 66 | 60.7× | 1.64e-2 | 7.63e-2 |
| ABC-family proteins mediated transport | Reactome | 1 / 81 | 49.4× | 2.01e-2 | 8.59e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| inorganic cation transmembrane transport | GO:0098662 | 2 / 23 | 542× | 4.34e-6 | 2.83e-4 ✓ sig. |
| negative regulation of insulin secretion | GO:0046676 | 2 / 35 | 356× | 1.02e-5 | 5.52e-4 ✓ sig. |
| potassium ion import across plasma membrane | GO:1990573 | 2 / 46 | 271× | 1.78e-5 | 8.46e-4 ✓ sig. |
| action potential | GO:0001508 | 2 / 53 | 235× | 2.36e-5 | 1.05e-3 ✓ sig. |
| cellular response to nutrient levels | GO:0031669 | 2 / 83 | 150× | 5.83e-5 | 2.07e-3 ✓ sig. |
| negative regulation of neuroblast migration | GO:0061855 | 1 / 1 | 6,229× | 1.61e-4 | 4.34e-3 ✓ sig. |
| positive regulation of uterine smooth muscle relaxation | GO:1900721 | 1 / 1 | 6,229× | 1.61e-4 | 4.34e-3 ✓ sig. |
| potassium ion transmembrane transport | GO:0071805 | 2 / 150 | 83.1× | 1.91e-4 | 4.93e-3 ✓ sig. |
| potassium ion transport | GO:0006813 | 2 / 152 | 82.0× | 1.96e-4 | 5.02e-3 ✓ sig. |
| asparaginyl-tRNA aminoacylation | GO:0006421 | 1 / 2 | 3,115× | 3.21e-4 | 7.04e-3 ✓ sig. |
| glutamate secretion, neurotransmission | GO:0061535 | 1 / 3 | 2,076× | 4.82e-4 | 9.24e-3 ✓ sig. |
| negative regulation of blood-brain barrier permeability | GO:1905604 | 1 / 3 | 2,076× | 4.82e-4 | 9.24e-3 ✓ sig. |
| response to resveratrol | GO:1904638 | 1 / 3 | 2,076× | 4.82e-4 | 9.24e-3 ✓ sig. |
| response to xenobiotic stimulus | GO:0009410 | 2 / 248 | 50.2× | 5.22e-4 | 9.80e-3 ✓ sig. |
| positive regulation of tight junction disassembly | GO:1905075 | 1 / 5 | 1,246× | 8.03e-4 | 1.28e-2 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Diabetes, permanent neonatal, with or without neurologic features | Diazoxide-resistant focal hyperinsulinism due to kir6.2 deficiency | 0.500 | 1 | 6.46e-5 | 1.98e-4 ✓ sig. |
| Diabetes, permanent neonatal, with or without neurologic features | Hyperinsulinemic hypoglycemia, familial, 2 | 0.500 | 1 | 6.46e-5 | 1.98e-4 ✓ sig. |
| Diazoxide-resistant focal hyperinsulinism due to kir6.2 deficiency | Hyperinsulinemic hypoglycemia, familial, 2 | 0.500 | 1 | 6.46e-5 | 1.98e-4 ✓ sig. |
| Deafness, autosomal recessive 94 | Dend syndrome | 0.250 | 1 | 1.94e-4 | 4.41e-4 ✓ sig. |
| Dend syndrome | Diazoxide-resistant focal hyperinsulinism due to kir6.2 deficiency | 0.250 | 1 | 1.94e-4 | 4.41e-4 ✓ sig. |
| Dend syndrome | Hyperinsulinemic hypoglycemia, familial, 2 | 0.250 | 1 | 1.94e-4 | 4.41e-4 ✓ sig. |
| Dend syndrome | Diabetes, permanent neonatal, with or without neurologic features | 0.250 | 1 | 1.94e-4 | 4.41e-4 ✓ sig. |